Form 4 Filing by Immunovant, Inc. Officer

This filing details transactions made by Jay Stout, Chief Technology Officer of Immunovant, Inc. On October 7, 2026, Stout sold 2,213 shares of Common Stock at an average price of $32.06 to cover tax obligations related to the vesting of 4,761 restricted stock units (RSUs) granted on April 1, 2025. Additionally, on the same date, 1,596 shares were sold at the same average price to cover tax withholding obligations stemming from the vesting of 3,437 RSUs granted on April 2, 2024. These sales were mandated by the company's "sell to cover" policy for tax withholding and were not discretionary. The sales occurred in multiple transactions with prices ranging from $31.58 to $32.30 per share. Stout's post-transaction holdings are reported as 203,128 shares after the first sale and 201,532 shares after the second sale.